US FDA Scrutinizes Process Risks After Nitrosamines Found In ARBs

 
• By Bowman Cox
  
FDABldg1ExteriorWithCircle_1200x675
agency grows more cautious about impurities
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business